Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers

Immune checkpoint inhibitors (ICIs) have altered the treatment paradigm across a range of tumour types, including gastro-oesophageal cancers. For patients with any cancer type who respond, ICIs can confer long-term disease control and significantly improve survival and quality of life, but for patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Mark A., Middleton, Fearghas, Cagney, Hannah P., Petty, Russell D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505606/
https://www.ncbi.nlm.nih.gov/pubmed/34230609
http://dx.doi.org/10.1038/s41416-021-01425-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505606/
https://www.ncbi.nlm.nih.gov/pubmed/34230609
http://dx.doi.org/10.1038/s41416-021-01425-7

Ejemplares similares